I specialise in leading large-scale biomedical research programmes, with extensive experience delivering high-impact initiatives within IMI JU – IHI, Horizon Europe, EMA, and EIT Health frameworks. My expertise is in managing complex, multinational consortia and coordinating observational pharmacoepidemiological studies that shape the future of healthcare research.
What sets me apart is my leadership philosophy: I believe the success of ambitious projects depends not only on rigorous programme management and regulatory excellence, but also on the ability to inspire, align, and empower people. I excel at building trust across diverse stakeholders—industry, academia, regulators, and patient representatives—transforming complexity into collaboration and vision into results.
Driven by a deep commitment to quality and impact, I ensure that every project under my leadership meets the highest standards of integrity, safety, and compliance. At the same time, I focus on enabling teams to thrive, fostering innovation, and creating an environment where talent and ideas can flourish.
My work directly contributes to evidence-based decision-making, patient safety, and accelerated access to innovative healthcare solutions. Whether navigating regulatory landscapes, leading cross-border partnerships, or guiding teams through times of uncertainty, I bring a strategic, people-centered approach to driving meaningful change in healthcare.
Alongside programme leadership, I serve as an editorial board reviewer for several international journals. Writing and critical review have become an extension of my professional practice, driven by a passion for advancing regulatory science. This blog emerges from that same motivation: to reflect on key regulatory challenges and opportunities, share insights across the healthcare community, and contribute to the dialogue that shapes a more adaptive, transparent, and trustworthy regulatory ecosystem.
Thanks for being part of this community!
Natasha Yefimenko, MSc, MBA, PhD
For more details, please visit Linkedin profile.